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Background: In the present study, we examined the antioxidant effect of water soluble derivative of propolis
(WSDP) and ethanolic (EEP) extract of propolis on renal and liver function in alloxan-induced diabetic mice.
In addition, we examined whether different extract of propolis could prevent diabetic nephropathy and liver
toxicity by inhibiting lipid peroxidation in vivo.
Methods: Diabetes was induced in Swiss albino mice with a single intravenous injection of alloxan (75 mg kg-1).
Two days after alloxan injection, propolis preparations (50 mg kg-1 per day) were given intraperitoneally for 7 days
in diabetic mice. Survival analysis and body weights as well as hematological and biochemical parameters were
measured. The renal and liver oxidative stress marker malonaldehyde levels and histopathological changes were
monitored in the liver and kidney of treated and control mice.
Results: Administration of propolis to diabetic mice resulted in a significant increase of body weight,
haematological and immunological parameters of blood as well as 100% survival of diabetic mice. Alloxan-injected
mice showed a marked increase in oxidative stress in liver and kidney homogenate, as determined by lipid
peroxidation. Histopathological observation of the liver sections of alloxan-induced diabetic mice showed
several lesions including cellular vacuolization, cytoplasmic eosinophilia and lymphocyte infiltrations, but with
individual variability.Treatment of diabetic mice with propolis extracts results in decreased number of vacuolized
cells and degree of vacuolization; propolis treatment improve the impairment of fatty acid metabolism in diabetes.
Renal histology showed corpuscular, tubular and interstitial changes in alloxan-induced diabetic mice. Test
components did not improve renal histopathology in diabetic mice.
Conclusions: Propolis preparations are able to attenuate diabetic hepatorenal damage, probably through its
anti-oxidative action and its detoxification proccess as well as the potential to minimize the deleterious effects
of free radicals on tissue. The protective role of propolis against the ROS induced damages in diabetic mice gives
a hope that they may have similar protective action in humans.
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Diabetes mellitus is possibly the World’s fastest growing
metabolic disorder, and as the knowledge of the hetero-
geneity of this disorder increases, so does the need for
more appropriate therapy [1]. Diabetes mellitus is a
pathologic condition, resulting in severe metabolic
imbalances and non-physiologic changes in many tis-
sues, where oxidative stress plays an important role in* Correspondence: norsolic@yahoo.com
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reproduction in any medium, provided the orthe aetiology [1,2]. Diabetes is associated with the gener-
ation of reactive oxygen species (ROS), which cause oxi-
dative damage, particularly to heart, kidney, eyes, nerves,
liver, small and large blood vessels, immunological and
gastrointestinal system [1,3].
Diabetic nephropathy (DN) is one of the important
microvascular complications of diabetes mellitus. Recent
studies indicate that reactive oxygen species (ROS) play
a key intermediate role in the pathophysiology of dia-
betic nephropathy [4]. Hyperglycaemia, the main deter-
minant of the initiation and progression of diabetic
nephropathy, not only generates more reactive oxygenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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isms through nonenzymatic glycosylation of anti-oxidant
enzymes [1]. The mechanism by which hyperglycaemia
causes free radical generation and, thus, causes oxidative
stress is complex. High glucose concentration directly
increases hydrogen peroxide production by murine
mesangial cells and lipid peroxidation of glomeruli and
glomerular mesangial cells [5]. Hyperglycaemia promotes
glycosylation of circulating and cellular protein and may
initiate a series of auto-oxidative reactions that culminate
in the formation and accumulation of advanced glycosy-
lation end-products (AGE) in tissue proteins [6,7].
The AGE has oxidizing potential and can promote
tissue damage by free radicals. In addition, increased
lipid peroxidation impairs membrane functions by
decreasing membrane fluidity and changing the activity
of membrane-bound enzymes and receptors. Its products
(lipid radicals and lipid peroxides) are harmful to the
cells in the body and associated with atherosclerosis and
damage to brain, kidney, liver and other tissue [1,8]. In
addition, diabetes and hyperglycemia can be sources of
DNA damage via the oxidation of DNA bases and sugar-
phosphate binding sites [9]. The occurrence of these
alterations can result in mutagenic effects and/or DNA
replication arrest, and could be associated with risks for
developing cancer in diabetes mellitus patients [10,11].
Propolis is a complex resinous material collected by
honeybees from buds and exudates of certain plant
sources neighbouring its hives. Propolis consisting of
sap, bark and bee excreta accumulates in bee hives.
Complexity and variety of the chemical composition of
propolis has been reported in the literature. From differ-
ent botanical and geographical origins of world, more
than 300 compounds including volatile organic com-
pounds, flavonoid aglycones, phenolic acids and their
esters, phenolic aldehydes, alcohols and ketones, sesqui-
terpenes, quinones, coumarins, steroids, aminoacids
were reported to have been isolated from propolis [12-14].
The main types of flavonoids are galangin, chrisin, pino-
cebrin and caffeic acid phenethyl ester [13-15].
Propolis possesses a broad spectrum of biological
activities and has a historical utilization in folk medi-
cine. Thus, it is extensively being used in health food,
pharmaceutical preparations [16] and beverages with the
aim of maintaining or improving human health [1].
It was reported that propolis enhances immune system
activities [17-20], oxygen radical scavenging [21], anti-
microbial [22-24] and antitumor activities [18,25,26].
Flavonoids, present in propolis, are plant phenolic
compounds with strong antioxidant properties. Propolis,
a potent anti-oxidant, scavenges free radicals directly
[27-29], inhibits xanthine oxidase [30], inhibits lipid per-
oxidation [31] and alters anti-oxidant defence pathway
in vivo and in vitro [32].Recently, it has been reported that propolis inhibits
oxidative damage in various tissues of alloxan- or
streptozotocin-induced diabetic animals [16,33]. And
while the people spontaneously develop diabetes, in
animals it can be induced by partial pancreatectomy or
by the administration of diabetogenic drugs such as
alloxan, streptozotocin, ditizona and anti-inzulin serum.
Alloxan can induce several processes: oxidation of –SH
groups, inhibition of glucokinase, generation of free radi-
cals and disturbances in calcium homeostasis [9]. Such
data support the use of alloxan-induced diabetes as
a model for the oxidative stress status experienced by
diabetic patients.
The present study was designed to investigate the
effect of different extracts of poplar-type propolis (water
and ethanolic solution) on lipid peroxidation, renal and
liver functions, and possibilities of natural anti-oxidants,
such as propolis, to protect or attenuate the damage of
the kidney and liver in alloxan-induced diabetic mice.
Methods
Animals
Present study was approved by the ethical committee
(Faculty of Science, University of Zagreb, Croatia). Male
and female Swiss albino inbred mice 2 to 3 months old,
weighing 20 to 25 g, obtained from Department of Ani-
mal Physiology, Faculty of Science, University of Zagreb,
were used in this study. The animals were kept in indi-
vidual cages during the experiment and at 12 hours of
light per day. They were fed a standard laboratory diet
(4 RF 21, Mucedola, Settimo Milanese, Italy) and tap
water ad libitum. Maintenance and care of all experi-
mental animals were carried out according to the guide-
lines in force in Republic of Croatia (Law on the Welfare
of Animals, N.N. #19, 1999) and carried out in compli-
ance with the Guide for the Care and Use of Laboratory
Animals, DHHS Publ. # (NIH) 86–123.
Water-soluble derivative of propolis (WSDP)
Row Croatian propolis was collected by scraping it
off from hive frames. The collected propolis samples
were kept desiccated in the dark until analysis at
room temperature. Water-soluble derivative of propolis
(WSDP) was prepared by the method described in our
previous paper [17]. Briefly, Croatian propolis from bee-
hives kept at the outskirts of Zagreb was extracted with
96% ethanol, which was filtered and evaporated to dry-
ness in vacuum evaporator. The resultant resinous prod-
uct was added to a stirred solution of 8% L-lysine (Sigma
Chemie, Deisenhofen, Germany) and freeze-dried to
yield the WSDP, a yellow-brown powder.
The chemical profile of propolis from the northern
hemisphere, often named as “poplar-type” propolis can
be characterized by the three analytical parameters: total
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droflavonol content, and total polyphenolics content.
According to Popova et al. [34], spectrophotometric pro-
cedures for quantification of the three main groups of
bioactive substances in propolis could be used for quality
assessment of different propolis samples, and results of
those analyses correlate with biological activity, espe-
cially in the “poplar-type” of propolis. The spectrophoto-
metric assay based on the formation of aluminium
chloride complex was applied for quantification of total
flavones/flavonols and expressed as quercetin equivalent.
For the quantification of flavanones and dihydroflavonols
propolis, we used 2,4-dinitrophenylhydrazine method
[35]. Total polyphenolics content was measured by the
Folin–Ciocalteu procedure [21]. Total phenol content
was expressed as gallic acid equivalents (mg/g), total
flavonoid contents as quercetin equivalents (mg/g), while
total flavanones and dihydroflavonols content was
expressed as naringenin equivalents (mg/g) from calibra-
tion curves recorded for the standards.
WSDP contained: flavones and flavonols 2.13%, flava-
nones and dihydroflavonols 9.06%, total flavonoids
11.19%, total polyphenols 70.48%.
Ethanolic extract of propolis (EEP)
Ethanolic propolis extract (EEP) was prepared by the
method described elsewhere [13,36]. Briefly, propolis
(10 g) was crushed into small pieces in a mortar and
mixed vigorously with 34.85 ml 80% (V/V) ethanol dur-
ing 48 h at 37 ± 1°C. After extraction, the ethanolic
extract of propolis was filtered through Whatman N0. 4
paper and than the extract was lyophilized. Spectro-
photometric analysis has shown that EEP contained:
flavones and flavonols 1.6%, flavanones and dihydrofla-
vonols 38.60%, total flavonoids 40.20%, total polyphenols
84.40%.
Antioxidant capacity of the extracts
β-Carotene−linoleic acid assay
The antioxidant activity of the extracts was evaluated
using β-carotene−linoleic acid system according to
Amarowicz et al. [37]. In short, 1 mL of β-carotene solu-
tion in chloroform (0.2 mg mL-1) was pipetted into a
round-bottom flask. To the solution, 20 mg of linoleic
acid and 200 mg of Tween 40 were added. After remov-
ing chloroform in a rotary evaporator, 50 mL of aerated
distilled water was added to the oily residue. Aliquots
(5 mL) of thus obtained emulsion were transferred to a
series of tubes containing 2 mg of extract or 0.5 mg of
BHA (positive control). Emulsion without antioxidant
served as control. After addition of the emulsion to the
tubes, they were placed in a water bath at 50°C for 2 h.
During that period, the absorbance of each sample was
measured at 470 nm at 15 min intervals, startingimmediately after sample preparation (t= 0 min) until
the end of the experiment (t = 120 min). The rate of
β-carotene bleaching (R) for the extracts, BHA and
water, was calculated according to first-order kinetics. The
percent of antioxidant activity (ANT) was calculated as
described in Al-Saikhan et al. [38], using the equation:
ANT ¼ ðRcontrol  RsampleÞ=Rcontrol  100
where Rcontrol and Rsample are average bleaching rates
of water control and antioxidant (plant extract or
BHA), respectively.
DPPH radical-scavenging activity
The scavenging effect for DPPH free radical was moni-
tored as described in Zovko Končić at al. [39] with
minor modification. Briefly, 1.0 mL of 0.16 mM DPPH
methanolic solution was added to 1.0 mL of either
methanolic solution of extract (sample) or methanol
(control). The mixtures were vortexed and then left
to stand at room temperature in the dark. After 30 min
absorbance was read at 517 nm. Radical-scavenging
activity (RSA) for DPPH free radical was calculated
using the following equation:
RSA ¼ ðAcontrol  AsampleÞ=Acontrol  100
where Acontrol is the absorbance of the methanol control
and Asample is the absorbance of the extract. Synthetic
antioxidant, BHA, was used as positive control. DPPH
radical-scavenging activity was calculated as the concen-
tration that scavenges 50% of DPPH free radical and
thus has RSA= 50% (EC50).
The reducing power of the extracts
The reducing power of extracts was determined accord-
ing to the method of Yen and Chen [40]. Briefly, extracts
(0.2–1.0 mg) were dissolved in 1.0 mL of distilled water
and mixed with 2.5 mL of 0.2 M phosphate buffer (pH
6.6) and 2.5 mL of 1% potassium ferricyanide. The mix-
tures were incubated at 50°C for 20 min. After incuba-
tion, 2.5 mL of a 10% trichloroacetic acid was added to
the mixtures. Following that, samples were centrifuged
for 10 min. Aliquots of 2.5 mL of the upper layer were
combined with 2.5 mL of water and 0.5 mL of the 0.1%
solution of ferric chloride. Absorbance of the reac-
tion mixture was read spectrophotometrically at 700 nm.
Ascorbic acid was used as positive control.
Chelating activity (ChA)
The chelation of iron (II) ions was studied as described
by Decker and Welch [41]. An aliquot of the extract in
methanol (1.3 mL) was added to 100 μL of 2 mM FeCl2.
After 5 min, the reaction was initiated by adding 200 μl
of 5 mM ferrozine. Following 10 min incubation at room
Oršolić et al. BMC Complementary and Alternative Medicine 2012, 12:117 Page 4 of 15
http://www.biomedcentral.com/1472-6882/12/117temperature, the absorbance at 562 nm was recorded.
For preparation of control, 1.3 mL of methanol was used
instead of extract solution. EDTA was used as a chelat-
ing standard. The Fe2+-chelating activity (ChA) was cal-
culated using the equation below:
ANT ¼ ðAcontrol  AsampleÞ=Acontrol  100
where Acontrol is the absorbance of the negative control
(solution to which no extract was added) and Asample is
the absorbance of the extract solution. Chelating activity
was expressed as ChEC50, the concentration that che-
lates 50% of Fe2+ ions and thus has ChA= 50%.
Experimental design
Seventy mice were randomly divided into four groups,
as follows:
Group (i): control animals (healthy, nondiabetic
animals); received 0.5 mL distilled water
intraperitonealy (i.p.) per day by injection for 7 days;
Group (ii): alloxan controls; injected i.v. with alloxan in
a single dose of 75 mg kg-1 body weight; these served
as the untreated diabetic group;
Group (iii): received WSDP i.p. in a daily dose of
50 mg kg-1 for 7 days starting 2 days after alloxan
injection; these served as the WSDP-treated diabetic
group.
Group (iv): received EEP i.p. in a daily dose of
50 mg kg-1 for 7 days starting 2 days after
alloxan injection; these served as the EEP -treated
diabetic group.
Five mice from each group were used on the 9th day
after alloxan injection. After desinfection of the external
abdominal region, each animal was inoculated with
3 mL of saline solution and after gentle agitation of the
abdominal wall, the solution containing peritoneal cells
was removed for cellular evaluation. The following vari-
ables were analyzed: toxicity analysis, animal weight loss,
hematological, biochemical parameters (total cholesterol
and triglyceride), determination of lipid peroxidation of
liver and kidney cells and their histopathological
analysis.
The remaining animals, i.e., 8–11 animals of each
group were used for the survival analysis (increased
lifespan).
Induction of experimental diabetes and determination
of serum glucose level
Diabetes was induced in Swiss albino mice by a single
intravenous injection of alloxan monohydrate (75 mg kg-1,
i.v.) in total volume of 0.5 mL of freshly prepared
saline solution. Blood glucose level was tested beforealloxan injection and 48 h after treatment, to monitor
the immediate diabetogenesis. After 48 h, the animals
with blood glucose level above 11 mmol L-1 were
selected for the study (diabetic mice) and then treated
with WSDP or EEP. Blood glucose level was determined
by test strips of blood glucose (Betachek Visual blood
glucose test strips, Sydney, Australia).
Effect of WSDP or EEP on body weight in alloxan induced
diabetic mice
During the study period of 50 days, the body weights of
the mice were recorded every 4 days using an electronic
balance. From these data, the mean change in body
weight was calculated. The maximum percentage of
animal weight loss, an indicator of toxicity, was calcu-
lated for individual animals as:
% animal weight loss
¼ Day 1 weight minimum weight on studyð Þ½
=Day 1 weight  100
Survival analysis
For the survival analysis Swiss albino mice were given
test components i.p. at doses of 50 mg kg-1 for 7 days
starting 2 days after the alloxan injection. The end point
of the experiment was determined by the spontaneous
death of animals. The results are expressed as percent-
age of mean survival time of the treated animals over
the mean survival time of the control group with dia-
betes (treated vs. control, T/C%). The percentage of
increased lifespan (ILS%) was calculated according the
formula: ILS% ¼ T Cð Þ=C 100 where T represents
mean survival time of treated animals and C represents
mean survival time of the control group.
Haematological analysis
The haematological analysis was performed on blood
obtained from the tail vein of experimental and control
mice on day 9 after alloxan injection. Blood was col-
lected into EDTA tubes. The measurement of the
leukocyte, erythrocytes, haemoglobin, hematocrit, MCV,
MCH, MCHC and platelets was made in an automatic
cell counter (Cell-DynW 3200, Abbott, USA).
Serum samples and biochemical determinations
Animals were treated with test components, blood sam-
ples were collected and centrifuged at 2200 rpm for
10 minutes. Serum was used for the determination of
total protein, glucose, urea, creatinine, bilirubin, alcaline
phosphatase (ALP), aspartate and alanine aminotrans-
ferases (AST and ALT) and lactic dehydrogenase (LDH).
Biochemical parameters were made using serum samples
from both control and experimental groups in an
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cholesterol were determined by enzymatic methods
according to the commercial kit’s instructions (Thermo
Electron, Australia). The total concentration of triglycer-
ides or total cholesterol was estimated by measuring the
absorbance of sample and standard by spectrophotom-
eter (Shimadzu, UV-160) at a wavelength of 500 nm.
Prepations of tissue homogenate and protein estimation
Samples of liver and kidneys (100 mg mL-1 buffer) were
homogenized in 50 mM phosphate buffer (pH 7.0), and
then centrifuged at 10,000 rpm for 15 min; the super-
natant thus obtained was used for biochemical analysis.
The protein concentration in each fraction was deter-
mined by the standard laboratory procedure [42], at
NanoDrop 1000 Spectrophotometer V3.7. using crystal-
line bovine serum albumin as standard.
Determination of lipid peroxidation
The extent of lipid peroxidation was determined by the
method of Ohkawa et al. [43]. To a tube containing
0.2 mL of 8.1% sodium dodecyl sulfate, 1.5 mL of 20%
acetic acid (pH 3.5), and 1.5 mL of 0.81% thiobarbituric
acid aqueous solution were added. To this reaction mix-
ture, 0.2 mL of each tissue homogenate was added. The
mixture was then heated in boiling water for 60 min.
After cooling to room temperature, 5 mL of butanol:
pyridine (15:1, v/v) solutions were added. The mixture
was then centrifuged at 5000 rpm for 15 min. The upper
organic layer was separated, and the intensity of the
resulting pink color was read at 532 nm. Tetramethoxy-
propane was used as an external standard. The level of
lipid peroxides was expressed as nmoles of malondialde-
hyde (MDA) formed/mg protein.
Histopathological analysis
For the histopathological changes, liver and kidney tis-
sues from diabetic control mice treated with physio-
logical and ethanolic solution and diabetic mice treated
with WSDP and EEP were fixed in 10% neutral buffered
formalin for 24 hours, dehydrated in a graded alcohol
series and after chloroform treatment embedded in para-
plast. Deparaplasted 5–6 μm thick sections were stained
with hematoxylin and eosin (HE) following standard
protocol. Stained slides were examined under a light
microscope (Nikon Eclipse E600) at 100, 200, 400 and
1000x magnification. Liver sections were examined for
vacuolization, lymphocyte infiltrations, necrosis and
apoptosis. The percentage of apoptotic cells was deter-
mined by counting 200 cells in randomly selected micro-
scopical fields of vision.
Kidney sections were examined for lymphocyte infil-
trations, reduction of Bowman’s spaces and changes in
renal tubules.Photomicrographs were taken by digital camera
(Nikon DMX1200) and Imaging Software Lucia G 4.80
(Laboratory Imaging Ltd., Prague, Czechoslovakia).
Statistical analyses
The experiments were performed in triplicate. The
results were expressed as mean ± SD. Statistical compar-
isons were made using one-way ANOVA, followed by
Dunnett’s post-hoc test for multiple comparisons with
the control and Student’s t-test for comparison between
samples. Statistical analyses were performed using the
JMP V6 from SAS software (SAS Institute, Cary, NC,
USA). A value of P < 0.05 was considered to indicate
statistical significance.
Results
Effect of alloxan on blood glucose level
Alloxan at dose of 75 mg kg-1 successfully causes dia-
betes in mice. Blood glucose level was strongly elevated
on the second day after treatment and the average levels
of blood glucose in each group of mice ranging between
20–30 mmol L-1 (data not shown).
Effect of WSDP or EEP on body weight and survival of
alloxan-induced diabetic mice
Effect of WSDP or EEP on body weight of mice with al-
loxan–induced diabetes is shown in Figure 1 and Table 1.
Body weight was rapidly reduced in animals treated with
alloxan alone; the fall was the largest between 3 and
10 days, and then body weight started to recover easily,
especially in diabetic animals treated with WSDP, which
have almost reached a mass of healthy (nondiabetic) ani-
mals. During the experiments, 3 or 4 animals died from
the untreated group of mice with diabetes, while animals
treated with test components are all survivors as shown
in Table 1. Increased life span (ILS) was observed in
treated diabetic mice with both WSDP and EEP prepara-
tions for 30.43% and 20.67%, respectively, in relation to
control diabetic mice.
Effect of WSDP or EEP on haematological and
biochemical parameters
Tables 2 and 3 show haematological and biochemical
parameters in normal (nondiabetic) animals and experi-
mental animals in each group. The level of the total
number of red blood cells, haemoglobin and hematocrit
level were significantly elevated in diabetic mice treated
with WSDP or EEP preparations (RBC, and HGB,
P <0.05; HCT, P <0.01 or P <0.05) compared to untreated
diabetic mice. Significantly reduced values of the platelet
number are observed in the group of animals treated
with both propolis preparations (WSDP, EEP) compared
with diabetic mice without treatment (P <0.05). Other
Figure 1 Effect of WSDP or EEP on body weight of alloxan-induced diabetic mice. Control group of nondiabetic mice received 0.5 mL
physiological solution intraperitonealy (ip) for 7 consecutive days starting starting 2 days after aloxan injection.Diabetic mice; injected iv with
alloxan in a single dose of 75 mg kg-1 body weight and served as untreated diabetic group.Untreated diabetic mice received 0.5 mL
physiological solution intraperitonealy (ip) or 0.5% ethanolic solution for 7 consecutive days starting starting 2 days after aloxan injection. Diabetic
mice treated with water-soluble derivative of propolis (WSDP) or ethanoloc extract of propolis (EEP) ip in a daily dose of 50 mg kg-1 for 7 days
starting 2 days after alloxan injection.
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cant differences (Table 2).
As shown in Table 3 alloxan elevated values of ALP
and LDH; a statistically significant difference exists be-
tween diabetic mice (P <0.05 or P <0.01) and nondia-
betic animals. In diabetic mice treated with WSDP or
EEP there was a reduction in levels of ALT (P <0.05),
ALP, and LDH (P <0.01 or P <0.001), in relation to
animals with diabetes without treatment. Statistically
significant increase in levels of urea was noticed in dia-
betic groups treated with EEP (P <0.05) compared to
healthy (nondiabetic) animals. Trigliceride levels were
lower in propolis-treated diabetic mice than in untreated




In the liver of control diabetic mice, treated with a phy-
siological solution, the majority of hepatocytes containedTable 1 Survival of untreated diabetic mice and diabetic mice
Experimental group Range of survival (days) Media
Diabetic micea 15-45 38.5 ±
Diabetic mice + (0.5% EtOH) 22-45 42 ±
Diabetic mice +WSDPb 45 4
Diabetic mice + EEPb 45 4
aDiabetic mice; injected iv with alloxan in a single dose of 75 mg kg-1 body weight
0.5 mL physiological solution or 0.5% ethanolic solution intraperitonealy (ip) for 7 c
bDiabetic mice treated with WSDP or EEP ip in a daily dose of 50 mg kg-1 for 7 day
cILS% (increased life span%) = (T-C)/Cx100. T, mean survival time of treated diabetic
dT/C treated diabetic animals versus untreated diabetic animals.
eLTS- Long-term survivors; mice surviving more than 45 days after alloxan treatmen
Results are expressed as the means of each group (n = 8) of and are representative
*Statistically significant difference between WSDP or EEP treated diabetic mice andempty vacuole-like spaces. Hepatocytes around Kiernan’s
spaces were more intensively vacuolized than the cells
around central veins (Figure 2A). In contrast, in one
sample, hepatocytes around central veins were more inten-
sively vacuolized than the hepatocytes around Kiernan’s
spaces. In all samples, small lymphocyte infiltrations
were observed in parenchyma and beside vessels in some
Kiernan’s spaces. Focal hemorrhagic necrosis was also
found (Figure 2B).
In diabetic mice treated with WSDP, half of the sam-
ples were similar to control, however the hepatocytes
were less vacuolized, but not significantly. In the other
half of the samples histological image was quite different.
Sinusoids were dilatated and hepatocytes around central
veins were swollen but not vacuolized (Figure 2C). In the
area around Kiernan’s spaces, small amount of weakly
vacuolized hepatocytes were observed (Figure 2C). The
rest of the hepatocytes were not vacuolized nor swollen.
In these samples smaller lymphocyte infiltrations were
found only in parenchyma. Focal hemorrhagic necrosistreated with WSDP or EEP
n ± SD ILS%c T/C%c Long-term survivors (LTS)f
13.12 - - 3
9.68 - - 4
5* 30.43 130.43 8
5* 20,67 120,67 8
and served as untreated diabetic group. Untreated diabetic mice received
onsecutive days starting starting 2 days after aloxan injection.
s starting 2 days after alloxan injection.
group; C, mean survival time of untreated diabetic group.
t.
of two independent experiments.
untreated diabetic animals (*P <0.05; Log-Rank test).
Table 2 Haematological parameters of nondiabetic mice, untreated diabetic mice and diabetic mice treated with WSDP
or EEP
Nondiabetic micea Diabetic mice b Diabetic mice + (0.5% EtOH) Diabetic mice + EEPc Diabetic mice +WSDPc
WBC (×109 L-1) 4.85 ± 1.00 4.96 ± 0.81 4.41 ± 1.31 4.59 ± 3.18 3.3 ± 1.42
Mononuclear/% 57.06 ± 12.08 63.16 ± 6.24 51.73 ± 12.62 56 ± 19.90 53.38 ± 9.63
Polymorphonuclear/% 42.94 ± 12.00 36.84 ± 6.24 48.27 ± 12.62 44 ± 19.90 46.62 ± 9.63
RBC (x 1012 L-1) 9.13 ± 0.32 9.18 ± 0.33 9.435 ± 0.28 9.87 ± 0.46 *Δ 9.755 ± 0.14* Δ
HGB (g L-1) 135.55 ± 5.35 132.05 ±5.25 136.2 ± 3.67 139.85 ± 5.56 139.45 ± 1.75*
HCT (L L-1) 0.444 ± 0.02 0.44 ± 0.01 0.452 ± 0.01 0.47 ± 0.02* 0.4715 ± 0.00**
MCV (fL) 97.2 ± 1.91 96.2 ± 2.33 95.8 ± 1.50 95.4 ± 1.59 96.75 ± 1.84
MCH (pg) 29.7 ± 0.26 28.8 ± 0.69 28.9 ± 0.41 28.3 ± 0.50 28.6 ± 0.43
MCHC (g L-1) 616.7 ± 6.43 598.5 ± 5.26 603 ± 7.74 593.5 ± 1.91 591.5 ± 4.43
RDW (%CV) 24 ± 3.00 23.1 ± 1.16 23.6 ± 1.78 22.35 ± 1.30 22.35 ± 1.11
PLT (x 109 L-1) 1434.5 ± 373.75 1333.5 ± 330.52 1521.5 ± 251.01 805 ± 344.36* Δ 986 ± 151.85
MPV (fL) 9.76 ± 0.67 10.19 ± 0.24 9.92 ± 0.63 10.76 ± 1.05 9.97 ± 0.57
aControl group of nondiabetic mice received 0.5 mL physiological solution intraperitonealy (ip) for 7 consecutive days starting starting 2 days after alloxan
injection.
bDiabetic mice; injected iv with alloxan in a single dose of 75 mg kg-1 body weight and served as untreated diabetic group. Untreated diabetic mice received
0.5 mL physiological solution or 0.5% ethanolic solution intraperitonealy (ip) for 7 consecutive days starting starting 2 days after aloxan injection.
cDiabetic mice treated with WSDP or EEP ip in a daily dose of 50 mg kg-1 for 7 days starting 2 days after alloxan injection.
*Statistically significant difference between WSDP or EEP treated diabetic mice and untreated diabetic animals (*P <0.05; ** P <0.01; Student t-test).
Δ Statistically significant difference between nondiabetic animals and WSDP or EEP treated diabetic mice (Δ P <0.05; ΔΔ P <0.01; Student t-test).
Oršolić et al. BMC Complementary and Alternative Medicine 2012, 12:117 Page 7 of 15
http://www.biomedcentral.com/1472-6882/12/117was not found. Generally, the liver of diabetic mice trea-
ted with WSDP showed lower amount of vacuolized
hepatocytes with less vacuolization.
In the liver of control diabetic mice treated with
an ethanolic solution, in half of the samples, hepato-
cytes around central veins were more intensively
vacuolized, compared to the hepatocytes around
Kiernan’s spaces (Figure 2D). Smaller lymphocyte
infiltrations were found beside vessels in some Kiernan’s
spaces.Table 3 Biochemical parameters of nondiabetic mice, untreat
or EEP
Nondiabetic micea Diabetic mice b Diabetic
ALP (U L-1) 53.75 ± 7.50 83.33 ± 16.07#
AST (U L-1) 146.25 ± 13.50 186.25 ± 31.72 1
ALT (U L-1) 57.5 ± 9.36 81.25 ± 9.46
LD (g L-1) 1881 ± 298.48 2246.25 ± 157.92# 2
TP (g L-1) 48.5 ± 4.38 44.5 ± 1.96
GLU (mmol L-1) 9.89 ± 0.64 30.52 ± 5.34## 2
UREA (mmol L-1) 7.5 ± 1.22 9.125± 0.42
Cholesterol (mmol L-1) 3.52 ± 0.26 3.20 ± 1.00
Triglycerides (mmol L-1) 2.72 ± 0.16 3.00 ± 0.90
aControl group of nondiabetic mice received 0.5 mL physiological solution intraperi
injection.
bDiabetic mice; injected iv with alloxan in a single dose of 75 mg kg-1 body weight
0.5 mL physiological solution or 0.5% ethanolic solution intraperitonealy (ip) for 7 c
cDiabetic mice treated with WSDP or EEP ip in a daily dose of 50 mg kg-1 for 7 days
*Statistically significant difference between WSDP or EEP treated diabetic mice and
# Statistically significant difference between untreated diabetic mice and nondiabet
Δ Statistically significant difference between nondiabetic animals and WSDP or EEPIn the other half of the samples, almost all hepatocytes
were significantly vacuolized, with no difference in the
level of cell vacuolization between the central and per-
ipheral part of the lobules (Figure 2E). In these samples,
lymphocyte infiltrations were not found.
In diabetic mice treated with EEP, hepatocytes around
central veins were more intensively vacuolized compared
to the hepatocytes around Kiernan’s spaces, but in the
majority of the samples they were less vacuolized
according to the control (Figure 2F). In these samples,ed diabetic mice and diabetic mice treated with WSDP
mice+ (0.5% EtOH) Diabetic mice + EEPc Diabetic mice +WSDPc
95 ± 10.80## 71.25 ± 20.15 65 ± 10.80
83.75 ± 41.70 167.5 ± 29.58 161.25 ± 29.54
90 ± 15.35 66.25 ± 11.09* 60 ± 10.80*
487.5 ± 253.42# 995± 358.86*** ΔΔΔ 586.25 ± 90.68**ΔΔ
48.75 ± 4.92 40.75 ± 4.78 40.875 ± 1.93 Δ
5.575 ± 4.55# 32.57 ± 7.47 ΔΔΔ 47.75 ± 6.35 ΔΔ
9.88 ± 1.89 13.625± 3.45 Δ 7.88 ± 2.43
3.20 ± 0.80 4.14 ± 2.36 3.55 ± 0.72
3.37 ± 1.11 2.20 ± 0.97 2.56 ± 0.92
tonealy (ip) for 7 consecutive days starting starting 2 days after aloxan
and served as untreated diabetic group.Untreated diabetic mice received
onsecutive days starting starting 2 days after aloxan injection.
starting 2 days after alloxan injection.
untreated diabetic animals (*P <0.05; P** < 0.01; Student t-test).
ic animals (## P <0.01; Student t-test).
treated diabetic mice (Δ P <0.05; ΔΔ P <0.01; ΔΔΔ P <0.001; Student t-test).
Figure 2 Liver of diabetic mice stained with HE. (A-B) Diabetic mice treated with physiological solution. (A) Hepatocytes around Kiernan’s
spaces (Ks) are more vacuolized then cells around central vein (vc). (B) Focal hemorrhagic necrosis. (C) Diabetic mice treated with WSDP show
less vacuolized hepatocytes. Dilatated sinusoids and swollen hepatocytes without vacuoles can be seen around central vein (vc). Cells around
Kiernan’s space (Ks) are not swollen, some are weakly vacuolized. (D-E) Diabetic mice treated with ethanolic solution (0.5% EtOH). (D) Hepatocytes
around central vein (vc) are more intensively vacuolized then cells around Kiernan’s space (Ks). (E) Increased number and level of vacuolized
hepatocytes in whole lobule. (F) Diabetic mice treated with EEP. Hepatocytes are less vacuolized compared to diabetic mice. Bar = 20 μm.
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sels in some Kiernan’s spaces, as well as in parenchyma.
Focal hemorrhagic necrosis was also found.
Generally, hepatocytes in diabetic mice treated with
EEP were less vacuolized compared to untreated diabetic
mice, but not significantly.
n the liver of all diabetic mice exposed to physio-
logical and ethanolic solution separately as well as in
combination with propolis, necrotic and apoptotic
cells were found. The quantitative analysis of apop-
totic cells is shown in Figure 3. The results showed
that the liver of diabetic mice after treatment with
EEP had 20% less apoptotic cells compared toadequate control. WSDP had no effect in preventing
apoptosis.
Kidney
In the kidneys of control diabetic mice treated with a
physiological solution changes were observed in the
renal corpuscles and in the renal tubules. Majority of
Bowman’s spaces were very narrow or totally reduced
(Figure 4A). Differentiation of squamous cells in the par-
ietal layer of Bowman’s capsule into columnar cells was
also noticed (Figure 4A). In one sample, Bowman’s
spaces were not narrow, some were even expanded,
while parietal layers of Bowman’s capsule were mostly
Figure 3 Number of apoptotic cells in the liver of diabetic mice treated with physiological and ethanolic solution (0.5% EtOH) and
diabetic mice treated with WSDP and EEP. Data are mean ± SD and represent percentages of apoptotic cells in total of 200 cells.
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cells showed signs of necrosis, i.e. had more eosinophilic
cytoplasm and decreased nuclei (Figure 4A-C). In most
of the samples, basophilic cells with or without larger
nuclei appeared in the wall of some tubules (Figure 4B).
Tubules with cytoplasmic vacuolization (Figure 4B-D),
tubules with vacuole-like spaces in the lumen with or
without granular content (Figure 4C), tubules with
thinned epithelium, with or without intraluminal light
eosinophilic mass (Figure 4D) and dilated tubules
(Figure 4E) were also found in the outer cortex and par-
ticulary in the deep cortex and in the medulla close to
deep cortex. Smaller or larger lymphocyte infiltrations
were found in the cortex of all samples (Figure 4E),
while in the half of them, very small infiltrations were
also found in the medulla.
Kidneys of diabetic mice treated with WSDP showed
similar changes to control diabetic mice but with much
larger lymphocyte infiltrations and more dilated tubules
in the outer cortex (Figure 4F).
Kidneys of control diabetic mice treated with an etha-
nolic solution had significantly less lymphocyte infiltra-
tions and less eosinophilic proximal tubules compared
to the kidneys of control diabetic mice treated with
a physiological solution. Few tubules with basophilic
cytoplasm were found in only one sample, while in
others, basophilic tubules had light cytoplasm and larger
nuclei. In one sample, tubules with thinned epithelium
and eosinophilic mass in the lumen were found in
greater numbers.
Kidneys of diabetic mice treated with EEP showed
similar changes to control diabetic kidneys treated with
an ethanolic solution. In all samples there were changes
in renal corpuscles, presence of vacuolized tubules,
tubules with intraluminal vacuole-like spaces, tubules
with thinned epithelium with or without intraluminaleosinophilic mass and necrotic tubules. Most of the
samples had few basophilic tubules, while in one sample
such tubules were more numerous and occupied large
area of deep cortex. In the same sample large lympho-
cyte infiltrations were also found. Other samples had less
or more lymphocyte infiltrations compared to control.
In most samples, in the outer cortex occasional tubules
were more dilated compared to control. In one sample
they were extremely dilated.Effect of propolis preparation on lipid peroxidation of
kidney and liver
The principle of lipid peroxidation is the reaction of
MDA, an end product of lipid peroxidation, with thio-
barbituric acid (TBA) to form a pink chromogen. The
levels on MDA in liver and kidney of untreated diabetic
animals and diabetic animals treated with WSDP and
EEP are presented in Figure 5. The lipid peroxidation in
liver tissue was notably improved in animals treated by
EEP and WSDP (P <0.001). In addition, WSDP was
able to lower the extent of lipid peroxidation of kindey
(P <0.05).Antioxidant capacity of the extracts
The basis of β-carotene−linoleic acid assay is degrad-
ation of β-carotene in reaction with linoleic acid
free radical. Antioxidants present in the solution can
hinder this reaction and consequently prevent discolor-
ation of β-carotene solution.The reduction of absorbance
of β-carotene−linoleic acid emulsion in presence of
the extracts is shown in Figure 6. Comparison of the
ANT values of the samples (Table 4) indicates that the
WSDP was more successful at inhibition of bleaching of
β-carotene emulsion than BHA (P <0.0001) while EEP
showed lower activity than BHA (P <0.0001). However,
Figure 4 Kidney of diabetic mice stained with HE. (A-E) Diabetic mice treated with physiological solution. (A) The renal corpuscle with narrow
Bowman’s space (black arrowhead) and columnar cells in the parietal layer of Bowman’s capsule (white arrowhead). Tubular changes involve: (A-
D) presence of necrotic cells (nc), (B) presence of basophilic cells (bc), cytoplasmic vacuolization (arrows), (C) presence of vacuole-like spaces in
the tubular lumen (asterisk), (D) epithelial flattening with or without intraluminal eosinophilic mass (ef), and (E) dilated tubules (dt).
(E) The interstitium shows large lymphocyte infiltration (L). (F) Kidney cortex of diabetic mice treated with WSDP. More dilated tubules (dt) and
larger interstitial lymphocyte infiltrations (L) compared to diabetic mice. Bar = 20 μm.
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of BHA.
The basis of DPPH assay is the discoloration of DPPH•
solution in presence of an antioxidant. In its radical form,
DPPH absorbs with maximum at 517 nm, but upon
reduction with an antioxidant, its absorption decreases
due to the formation of its non-radical form [44]. In
this study, EEP and WSDP demonstrated notable anti-
radical activities albeit lower than the activity of BHA
(P <0.0001) (Table 4). In another assay performed in this
study, reducing power assay, the yellow color of the test
solution changes to green and blue depending on thereducing power of test specimen. Greater absorbance at
700 nm indicates greater reducing power. Figure 7 pre-
sents the reductive capabilities of the propolis extracts.
Reducing power of the ascorbic acid and the extracts
increased with concentration. The increase tended to be
linear in case of the extracts (r2 ≥ 0.94), while the absorb-
ance of reaction mixture with ascorbic acid remained
relatively constant in higher concentrations (r2 = 0.81),
most likely due to limitations of Beer–Lambert law. Thus,
for purpose of comparison, slopes of the trend lines (SRP)
were calculated for three lowest concentrations where
r2 > 0.95 for all the samples (Table 4). The activity of
Figure 5 Levels of lipid peroxidation in liver and kidney of
nondiabetic mice, untreated diabetic mice and diabetic mice
treated with WSDP and EEP. Values are means ± SD (n = 4).
(Diferences with untreated diabetic mice * P <0.05; ** P <0.01;
Diferences with nondiabetic mice † P <0.05; { P <0.01; Student’s
t-test).
Table 4 Antioxidant activity in β-carotene-linoleate test
(ANT), radical scavenging activity (EC50), slope of
reducing power trendline (SRP) and metal chelating
activity (ChEC50) of WSDP and EEP
ANT (%) EC50 (μg/ml) SRP (mg
−1) ChEC50 (μg/ml)
EEP 87.3 ± 0.39#### 27.82 ± 0.44#### 0.56 ± 0.00#### n.d.
WSDP 96.81 ± 0.33#### 55.97 ± 1.50#### 0.53 ± 0.02#### 47.81 ± 0.34####
STD a91.67 ± 0.49 a6.02 ± 0.10 b7.53 ± 0.24 c7.18 ± 0.10
Values are means ± SD (n = 3).
n.d. − not detected.
STD − standard: a = BHA, b = ascorbic acid, c = EDTA.
# Statistically significant difference between sample and standard
(#### P <0.0001; Student t-test).
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the activity of ascorbic acid (P <0.0001).
Chelating activity
The chelating ability of the extracts toward ferrous ions
was investigated (Table 4) in presence of ferrozin, Fe2+
ion chelator, which upon binding of the metal ionab-
sorbs with maximum at 562 nm. In the investigated con-
centrations (0–1000 g mL-1) EEP of did not show any
chelating ability towards ferrous ion. WSDP, on the
other hand demonstrated significant chelating ability in
the present research, although lower than the ability of
EDTA (P <0.0001).
Discussion
In this paper the nephroprotective and hepatoprotec-
tive activities of water soluble derivative of propolis
and ethanolic propolis preparation were determined in
an alloxan-induced diabetic mice model. Our data
showed that treatment of diabetic mice with WSDP or
EEP resulted in marked increase in animal body weight
(Figure 1) as well as in life span of treated mice versusFigure 6 Inhibition of bleaching of β-carotene-linoleic acid
emulsion by the WSDP, EEP and BHA over 120 min. Values are
means ± SD (n = 3).untreated diabetic mice (Table 1). Interestingly, 37.5% or
50% of mice were long time survivors in untreated dia-
betic group versus a 100% survival of mice in diabetic
group treated with WSDP or EEP. Thus, this study sug-
gested that WSDP or EEP could be used to ameliorate
oxidative stress and the adverse effects of alloxan-
induced diabetes and delay the occurrence of pathogen-
esis of diabetic–associated diseases such as diabetic
nephropathy, atherosclerosis, and brain, liver and other
tissue damage in diabetes mellitus.
Body weight was rapidly reduced in animals treated
with alloxan alone; the fall was the largest between 3
and 10 days, and then body weight started to recover
easily. In diabetic animals treated with WSDP and/or
EEP body weight was slightly reducede, especially in
WSDP treated diabetic mice. Improved body weight of
diabetic mice treated with WSDP or EEP could be due
to a better control of hyperglycaemic state compared to
the untreated diabetic mice. It is likely that decreased
body weight in diabetic animals is due to dehydration
and catabolism of fats and proteins [45]. Increased cata-
bolic reactions leading to muscle wasting might also
be the reason for the reduced weight gain by diabetic
animals [46]. The findings of our study coincides with
the findings of Fuliang et al. [47], Abo-Salem et al. [48],
El-Sayed et al. [33] and Zhu et al. [31] and shows that
propolis reduces total level of cholesterol and triglycer-
ides in the blood of diabetic animals, reducing thus someFigure 7 Reducing powers of EEP, WSDP and ascorbic acid.
Values are means ± SD (n = 3).
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propolis preparations could modulate lipid metabolism
(Table 3) and reduce the syndrome caused by blood lipid
abnormalities [47]. Also, our data of the antioxidant
effects of propolis are parallel with Abo-Salem et al. [48]
who reported that both of propolis preparations, WSDP
and EEP, attenuates alloxan-induced hepatotoxicity via
decreasing lipid peroxidation (Figure 5). Similar results
were demonstrated by Bhadauria et al. [49] who revealed
that propolis may play a hepatoprotective role through
reducing oxidative stress in living system. Our results
show that dietary intervention with propolis prepara-
tions (WSDP, EEP) reduces free-radical-induced lipid
peroxidation in liver. We could clearly observe the sig-
nificant decrease (P <0.05) in MDA concentration after
the initial 7 days of propolis supplementation. The lipid
peroxidation in liver was significantly lowered in diabetic
animals treated with oth EEP and WSDP in comparison
with untreated diabetic mice (Figure 5). As shown in
Table 3, alloxan administration induced a marked reduc-
tion in liver functions, as characterized by significant
increases in serum LDH, ALP, and AST levels, in mice
treated with alloxan alone compared to undiabetic mice.
In addition, our results demonstrated that propolis pre-
parations have the ability to decrease serum transferases
and LDH activity in alloxan-induced diabetic animals.
On the other hand, MDA lowering effect of EEP is not
observed kidney tissue. Acute alcohol consumption has
been known to enhance lipid peroxidation in the cere-
bellum, heart and other organs [50]. Therefore, it is pos-
sible that the putative MDA lowering effects of propolis
constituents were attenuated by alcohol present in the
extract. These data are consistent with biochemical para-
meters (Table 3) indicating increased levels of urea and
creatinin in the serum of untreated and propolis-treated
diabetic animals in comparison with nondiabetic mice.
However, administration of propolis to diabetic mice
significantly elevated hematological parameters such
as the total number of red blood cells, haemoglobin
and hematocrit level (RBC, and HGB, P <0.05; HCT,
P <0.01 or P <0.05) compared to untreated diabetic mice
(Table 2).
Histopathological observation of the liver sections of
alloxan-induced diabetic mice showed several lesions in-
cluding cellular vacuolization, cytoplasmic eosinophilia
and lymphocyte infiltrations, but with individual vari-
ability. The most prominent change was the presence of
smaller or larger vacuole-like spaces in the hepatocyte
cytoplasm. This was probably a result of increased quan-
tity of fat within cells due to impaired metabolism
of fatty acids. The presence of single or small foci of
eosinophilic cells and pale foci was another charac-
teristic of damaged cells indicating necrosis. Similarly,
Ragavan and Krishnakumari [51] found periportalvacuolization with focal necrosis in the rat liver treated
with single intraperitoneal injections of alloxan in a dose
of 120 mg kg-1 body weight, while Khalil et al. [52], with
a higher dose of 150 mg kg-1 found disorganization of
the hepatic cords and vacuolized hepatocytes with pic-
notic nuclei. Vinagre et al. [53] reported enlarged hepa-
tocytes with vacuolar cytoplasm and hypertrophic nuclei,
sinusoidal dilatation and lymphocyte infiltrations in the
periportal regions of streptozotocin-induced diabetic rat
(70 mg kg-1 bw). Al-Rawi [54] also showed sinusoidal
dilatation, swollen hepatocytes with marked cytoplasmic
vacuole, lymphocyte infiltrations around the portal veins
and severe fibrosis with a lower dose of streptozotocin
(50 mg kg-1 bw).
Our results showed that the treatment of diabetic mice
with both aqueous and ethanolic extracts of propolis
results in decreased number of vacuolized cells and
degree of vacuolization, although ethanolic extract had
stronger effect. These findings suggest that propolis
treatment may be able to improve the impairment of
fatty acid metabolism in diabetes.
Renal histology showed corpuscular, tubular and inter-
stitial changes. Changes in the corpuscles were related to
the reduction of Bowman’s space which could be due to
the expansion of mesangial and/or endothelial cells of
glomerulus. Expansion of mesangial region described
Hamada and Fukagawa [55] and Teoh et al. [56] Prabhakar
et al. [57] also reported extensive mesangial expansion
and basement membrane thickening. The role of the
mesangium is to support and anchor the capillary loops
to enable them to retain their structure and function.
Findings of Fioretto and Mauer [58] confirm that mesan-
gial expansion is crucial structural change leading to a
loss of renal function in diabetes. It is thought that such
expansion reduces the capillary surface area available for
filtration [59]. Increase in mesangium was shown to cor-
relate with the development of proteinuria, although
Wolf et al. [59] are not assured that mesangial expansion
is the only cause of the proteinuria as they argue that the
changes also occur within the visceral layer of Bowman’s
capsule which can lead to alterations in the glomerular
filtration barrier. We observed changes in the parietal
layer of Bowman’s capsule characterized as metaplasia.
Although parietal layer has no role in the glomerular fil-
tration, we assume that beside glomerular expansion, the
change of squamous epithelium into columnar could also
contribute to the reduction of Bowman’s space. It is
known that changes in the structure and function of the
glomerulus affect the tubules. Our findings revealed more
changes in renal tubules like dilatation, vacuolization,
epithelial flattening with or without intraluminal mass
and necrosis. Similar to our findings, Prabhakar et al. [57]
reported tubular dilatation and atrophy, Teoh et al. [56]
hypercellularity and necrosis of the proximal tubules while
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tion of the proximal tubules and the loop of Henle. We
also found tubules with cytoplasmic vacuolization and
tubules with intraluminal vacuole-like spaces in the deep
cortex and outer medulla. Cytoplasmic vacuoles could be
glycogenic or lipid as tubular cells in proteinuria reab-
sorbs lipids while intraluminal vacuoles could represent
small drops of fatty detritus as parenchymatous degener-
ation is usually associated with fatty degeneration [62].
All these tubular changes point to a disturbance in
their function. Our results show that treatment with an
aqueous or ethanolic extract of propolis does not im-
prove renal histopathology in diabetic mice.
Both propolis preparations, water and ethanolic
extract of propolis, offer a promising therapeutic value
in prevention of diabetes; propolis preparations reduce
free-radical-induced lipid peroxidation in liver but it
does not improve renal function in diabetic mice in
period observations (9 days). Data are consistent with
renal hystopathological observations. On the other hand,
since all treated diabetic mice are long–time survivor, it
is possible that renal repair process occurs later or that
kindney damages were not lethal for animals. This thesis
was confirmed by numberous authors in recent studies
that have shown that dietary agents with antioxidative
activity, including selenium, vitamin C, vitamin E, capsa-
icin from hot red peppers, and caffeic acid phenethyl
ester from honeybee propolis, can attenuate drug-
induced nephrotoxicity and hepatotoxicity based on
ROS production [29] and [32]. It is possible that propolis
may prevent hepatorenal injury by inhibiting lipid perox-
idation and enhancing the activities of antioxidant
enzymes as suggested by Abo-Salem et al. [48].
Propolis antioxidant activity has been demonstrated
using numerous in vitro tests [20] and [63]. In this study,
antioxidant activity was investigated using four assays
which cover different aspects of antioxidant activity.
Being a relatively stable free radical, DPPH• is frequently
used to determine radical-scavenging activity of natural
compounds. DPPH assay estimates the ability of sample
to scavenge free radicals, species capable of causing
damage to natural macromolecules, such as nucleic
acids, polysaccharides and lipids [64]. In this study,
the antiradical activity of EEP was more pronounced
than the activity of WSDP. This is in accordance with
some previous studies which showed a superior activity
of ethanolic extract over aqueous in this assay. For
example, antiradical activity of ethanolic extracts of
both, poplar-type propolis from Croatia and alecrim-
type Brazilian propolis, was greater than the activity of
their aqueous extracts [14].
In β-carotene−linoleic acid assay, the degradation of
β-carotene occurs in reaction with linoleic acid free rad-
ical formed at elevated temperatures. Subsequent lossof conjugation leads to a decrease in absorbance at
470 nm. Antioxidants present in the solution can prevent
the degradation of β-carotene by reacting with the linoleic
acid free radical or any other radical formed in the solu-
tion [37]. Thus, in this assay, the capacity of antioxidants
to prevent degradation of natural lipids, such as linoleic
acid, is measured. The reducing power of a compound, on
the other hand, is related to its electron transfer ability
and may serve as a significant indicator of its potential
antioxidant activity. It estimates the ability of a substance,
or an extract which contains it, to donate a proton, and
thus cause the transformation of free radicals into a less
reactive species. Interestingly, some previous findings indi-
cated that ethanolic propolis extracts were superior redu-
cers and inhibitors of β-carotene degradation [14]. In this
study, however, WSDP was more successful inhibitor of
β-carotene bleaching than EEP, while the reducing
powers of the two extracts were equal. Such differ-
ences in activity are probably caused by different method
of preparation of aqueous extract used in the study of
Kosalec et al. [14].
Hydroxyl radicals are among the most harmful ROS in
biological systems. Free ferrous iron is sensitive to oxy-
gen and gives rise to ferric iron and superoxide, thereby
generating hydrogen peroxide. Thus formed hydrogen
peroxide reacts with ferrous iron and generates the
hydroxyl radical, which may subsequently oxidize sur-
rounding biomolecules. In this process, known as the
Fenton reaction, hydroxyl radical production is directly
related to the concentration iron or other transition
ions. In pathological states involving iron overload or
impaired sequestering of iron by transport or storage
proteins, Fenton chemistry is an important generator of
ROS in vivo [65]. In the investigated concentration range
(0−1 mg mL-1) constituents of EEP were incapable of
chelating ferro ions in this assay. WSDP, on the other
hand demonstrated significant chelating ability. Some
previous studies showed that ethanolic extract of Brazil-
ian propolis showed chelating abilities [66]. Brazilian
propolis belongs to two groups of chemically different
types of propolis, alecrim and poplar type, respectively.
The differences in chemical compositions have probably
caused such different behavior of Croatian and Brazilian
propolis in presence of ferro ions. However, even in
the study of Wang et al. [66] the activity was achieved
only in relatively high concentration (EC50 was about
2 mg mL-1), which was not used in this study.
It has been reported that propolis contains various
phenolic substances. Some studies demonstrated that
the extracts having higher phenol content also have
higher DPPH radical-scavenging activity and other types
of antioxidant activities [67]. However, antioxidant activ-
ity of the WSDP was more pronounced in most of the
performed assays which leads to conclusion that besides
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be responsible for the antioxidant activity of investi-
gated extracts.
Conclusions
In conclusion, the administration of natural antioxidants
such as propolis mitigate alloxan-inuduced toxicity and
increase survival times of diabetic animals and attenu-
ates hepatotoxicity and nephrotoxicity by reducing
alloxan-induced oxidative stress in a diabetic mice
model. The findings of the present study strongly sug-
gest that oxidative stress has a pivotal role in the patho-
physiology of diabetic nephropathy and hepatotoxicity
and that propolis preparations are able to attenuate dia-
betic hepatorenal damage, probably through its anti-
oxidative action. The study implies that propolis could
be substituted as a dietary supplement to prevent or
treat diabetic complications.
Therefore, supplementation with propolis preparations
may be one approach that could be utilized to protect
animals or patients against oxidative stress induced dam-
age in diabetes. However, to clarify these observations
further studies are needed to investigate the associa-
tion between DNA damage of liver and kidney and its
repair in diabetic mice treated with propolis in long-
term period.
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